Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of its NeuroSite™ Coil Placement Accessory. The state-of-the-art tool, designed to …
Neuronetics Secures FDA Clearance for NeuroSite, Streamlining Mental Health Treatments Read More
EXTON, PA — In a move that strengthens its position as a global leader in innovative solutions for injectable drug administration systems, West Pharmaceutical Services, Inc. (NYSE: WST) recently announced …
West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company specializing in innovative solutions for mental health, has announced that its NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy System …
Neuronetics’ NeuroStar TMS Therapy System Receives Advanced Approval in Japan, Paving the Way for Enhanced Depression Treatment Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) recently announced that its Investigational New Drug application (IND) for CT-0525 has been cleared by the U.S. Food and Drug Administration (FDA). …
Carisma Therapeutics Receives FDA Clearance for Groundbreaking CAR-Monocyte Cellular Therapy Read More
The Federal Trade Commission (FTC) recently unveiled its Fiscal Year 2023 Agency Financial Report, spotlighting the agency’s accomplishments in safeguarding consumers and fostering competition. The report also reemphasizes the FTC’s …
FTC Releases Fiscal Year 2023 Agency Financial Report Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) this week announced that the Company’s fourth Investigational New Drug (IND) application for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational …
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis Read More
The U.S. Food and Drug Administration recently approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as …
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes Read More
NEWTOWN SQUARE, PA — ArriVent Biopharma, Inc. announced that the U.S. Food and Drug Administration (FDA) recently granted Breakthrough Therapy designation for furmonertinib for the treatment of patients with previously …
ArriVent Receives FDA Breakthrough Therapy Designation for Furmonertinib Read More
PHILADELPHIA, PA —Instanosis Inc., a diagnostic company based in Philadelphia, this week announced that its innovative InstaStrip-Fentanyl Rapid Test has achieved the Breakthrough Device designation by the United States Food …
Instanosis Announces FDA Breakthrough Device Designation for InstaStrip-Fentanyl Rapid Test Read More
The U.S. Food and Drug Administration recently amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to …
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants Read More